vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and OMEGA HEALTHCARE INVESTORS INC (OHI). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $323.0M, roughly 1.1× OMEGA HEALTHCARE INVESTORS INC). OMEGA HEALTHCARE INVESTORS INC runs the higher net margin — 49.1% vs -0.8%, a 49.9% gap on every dollar of revenue. On growth, OMEGA HEALTHCARE INVESTORS INC posted the faster year-over-year revenue change (16.7% vs 9.4%). Over the past eight quarters, OMEGA HEALTHCARE INVESTORS INC's revenue compounded faster (13.0% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Omega Healthcare Investors Inc is a specialized real estate investment trust that owns, leases and manages healthcare-related real estate assets, mainly including skilled nursing facilities, senior housing and long-term care facilities across the U.S. and UK. It partners with healthcare operators to provide stable real estate support for quality patient care delivery.
ASIX vs OHI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $323.0M |
| Net Profit | $-2.8M | $158.6M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | — |
| Net Margin | -0.8% | 49.1% |
| Revenue YoY | 9.4% | 16.7% |
| Net Profit YoY | -892.9% | 41.5% |
| EPS (diluted) | $-0.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $323.0M | ||
| Q4 25 | $359.9M | $319.2M | ||
| Q3 25 | $374.5M | $311.6M | ||
| Q2 25 | $410.0M | $282.5M | ||
| Q1 25 | $377.8M | $276.8M | ||
| Q4 24 | $329.1M | $279.3M | ||
| Q3 24 | $398.2M | $276.0M | ||
| Q2 24 | $453.5M | $252.7M |
| Q1 26 | — | $158.6M | ||
| Q4 25 | $-2.8M | $172.0M | ||
| Q3 25 | $-2.6M | $179.7M | ||
| Q2 25 | $31.4M | $136.6M | ||
| Q1 25 | $23.3M | $109.0M | ||
| Q4 24 | $352.0K | $116.5M | ||
| Q3 24 | $22.3M | $111.8M | ||
| Q2 24 | $38.9M | $113.9M |
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | -0.7% | 53.7% | ||
| Q3 25 | -0.9% | 61.4% | ||
| Q2 25 | 7.7% | 52.1% | ||
| Q1 25 | 7.7% | 41.4% | ||
| Q4 24 | -3.9% | 42.5% | ||
| Q3 24 | 7.5% | 40.3% | ||
| Q2 24 | 11.5% | 47.1% |
| Q1 26 | — | 49.1% | ||
| Q4 25 | -0.8% | 53.9% | ||
| Q3 25 | -0.7% | 57.7% | ||
| Q2 25 | 7.7% | 48.4% | ||
| Q1 25 | 6.2% | 39.4% | ||
| Q4 24 | 0.1% | 41.7% | ||
| Q3 24 | 5.6% | 40.5% | ||
| Q2 24 | 8.6% | 45.1% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.11 | $0.56 | ||
| Q3 25 | $-0.10 | $0.59 | ||
| Q2 25 | $1.15 | $0.46 | ||
| Q1 25 | $0.86 | $0.33 | ||
| Q4 24 | $0.02 | $0.41 | ||
| Q3 24 | $0.82 | $0.42 | ||
| Q2 24 | $1.43 | $0.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $26.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $5.2B |
| Total Assets | $1.7B | $10.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $26.1M | ||
| Q4 25 | $19.8M | $27.0M | ||
| Q3 25 | $23.7M | $737.2M | ||
| Q2 25 | $18.4M | $734.2M | ||
| Q1 25 | $8.3M | $368.0M | ||
| Q4 24 | $19.6M | $518.3M | ||
| Q3 24 | $17.3M | $342.4M | ||
| Q2 24 | $12.1M | $35.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $4.3B | ||
| Q3 25 | — | $5.0B | ||
| Q2 25 | — | $5.0B | ||
| Q1 25 | — | $4.4B | ||
| Q4 24 | — | $4.8B | ||
| Q3 24 | — | $4.9B | ||
| Q2 24 | — | $4.7B |
| Q1 26 | — | $5.2B | ||
| Q4 25 | $815.2M | $5.2B | ||
| Q3 25 | $818.2M | $5.0B | ||
| Q2 25 | $823.7M | $5.0B | ||
| Q1 25 | $794.4M | $4.7B | ||
| Q4 24 | $774.6M | $4.5B | ||
| Q3 24 | $766.4M | $4.2B | ||
| Q2 24 | $746.6M | $3.7B |
| Q1 26 | — | $10.2B | ||
| Q4 25 | $1.7B | $10.0B | ||
| Q3 25 | $1.7B | $10.6B | ||
| Q2 25 | $1.6B | $10.5B | ||
| Q1 25 | $1.6B | $9.7B | ||
| Q4 24 | $1.6B | $9.9B | ||
| Q3 24 | $1.5B | $9.6B | ||
| Q2 24 | $1.5B | $8.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.82× | ||
| Q3 25 | — | 0.99× | ||
| Q2 25 | — | 1.00× | ||
| Q1 25 | — | 0.94× | ||
| Q4 24 | — | 1.07× | ||
| Q3 24 | — | 1.15× | ||
| Q2 24 | — | 1.26× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | — |
| Free Cash FlowOCF − Capex | $36.1M | — |
| FCF MarginFCF / Revenue | 10.0% | — |
| Capex IntensityCapex / Revenue | 7.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.7M | $878.6M | ||
| Q3 25 | $26.6M | $226.7M | ||
| Q2 25 | $21.1M | $239.3M | ||
| Q1 25 | $11.4M | $182.0M | ||
| Q4 24 | $64.2M | $749.4M | ||
| Q3 24 | $57.3M | $184.9M | ||
| Q2 24 | $50.2M | $184.1M |
| Q1 26 | — | — | ||
| Q4 25 | $36.1M | $797.7M | ||
| Q3 25 | $66.0K | $205.5M | ||
| Q2 25 | $-7.2M | $226.5M | ||
| Q1 25 | $-22.6M | $161.8M | ||
| Q4 24 | $29.8M | $711.7M | ||
| Q3 24 | $26.8M | $176.6M | ||
| Q2 24 | $16.7M | $177.0M |
| Q1 26 | — | — | ||
| Q4 25 | 10.0% | 249.9% | ||
| Q3 25 | 0.0% | 65.9% | ||
| Q2 25 | -1.7% | 80.2% | ||
| Q1 25 | -6.0% | 58.4% | ||
| Q4 24 | 9.1% | 254.8% | ||
| Q3 24 | 6.7% | 64.0% | ||
| Q2 24 | 3.7% | 70.0% |
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | 25.3% | ||
| Q3 25 | 7.1% | 6.8% | ||
| Q2 25 | 6.9% | 4.5% | ||
| Q1 25 | 9.0% | 7.3% | ||
| Q4 24 | 10.4% | 13.5% | ||
| Q3 24 | 7.7% | 3.0% | ||
| Q2 24 | 7.4% | 2.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.11× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | 0.67× | 1.75× | ||
| Q1 25 | 0.49× | 1.67× | ||
| Q4 24 | 182.29× | 6.43× | ||
| Q3 24 | 2.57× | 1.65× | ||
| Q2 24 | 1.29× | 1.62× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
OHI
| Rental income | $266.9M | 83% |
| Other | $45.2M | 14% |
| Resident fees and services | $6.7M | 2% |
| Real estate tax and ground lease income | $3.8M | 1% |
| Miscellaneous income | $526.0K | 0% |
